In a recent blog post, it was reported that NuvaRing® plaintiffs had filed a master consolidated complaint in order to supplement the complaints in the individual NuvaRing® litigation cases. On May 19, 2009, the Court dismissed the class action claims in the Master Consolidated Complaint. The Court noted that such claims are usually not appropriate for personal injury lawsuits based on pharmaceuticals. However, the Court dismissed the claims without prejudice, which would allow Plaintiffs to reassert their rights to a class action, if such an assertion is appropriate at some time in the future. This dismissal did not affect the substantive claims of Negligence, Fraud, and other causes of action.
Home > Medical Devices > Court Dismisses Class Action Claims in NuvaRing® Litigation
Topics
Authors
Kevin M. Hart
Shareholder
Kevin is the Chairman and Senior Litigation Counsel of the Stark & Stark Mass Tort Litigation Group. Mr. Hart has over 30 years of experience as a trial attorney.
Craig S. Hilliard
Shareholder
Craig is a Shareholder and member of the Stark & Stark Mass Tort Litigation Group. Mr. Hilliard has extensive experience prosecuting and defending class actions involving securities and consumer fraud claims.
Martin P. Schrama
Shareholder
Martin is a Shareholder and member of the Stark & Stark Mass Tort Litigation Group. Mr. Schrama has extensive experience prosecuting and defending class actions involving securities, employment and consumer fraud claims.
Stefanie Colella-Walsh
Associate
Stefanie is an Associate and member of the Stark & Stark Mass Tort Litigation Group where she concentrates her practice in complex litigation with a focus in mass tort and pharmaceutical litigation.
Joseph M. DeFazio
Associate
Joseph M. DeFazio is an Associate and member of Stark & Stark's Litigation Group where he concentrates his practice in Mass Torts, Pharmaceutical Litigation and Intellectual Property matters.
Contact
How can we help? Any information you provide is considered confidential and will not be shared outside of our firm.

